Mercer Global Advisors Inc Biomarin Pharmaceutical Inc Transaction History

Mercer Global Advisors Inc

  • $35.2 Billion
  • Q1 2024

A detailed history of Mercer Global Advisors Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 12,272 shares of BMRN stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,272
Previous 12,535 2.1%
Holding current value
$1.01 Million
Previous $1.21 Million 11.33%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $22,042 - $26,037
-263 Reduced 2.1%
12,272 $1.07 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $13,719 - $17,731
-180 Reduced 1.42%
12,535 $1.21 Million
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $241,513 - $268,228
-2,839 Reduced 18.25%
12,715 $1.13 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $5,200 - $6,018
-60 Reduced 0.38%
15,554 $1.35 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $59,575 - $79,626
-679 Reduced 4.17%
15,614 $1.52 Million
Q4 2022

Feb 08, 2023
SELL
$80.93 - $108.63 $129,002 - $173,156
-1,594 Reduced 8.91%
16,293 $1.69 Million
Q3 2022

Nov 15, 2022
SELL
$82.16 - $96.94 $122,089 - $144,052
-1,486 Reduced 7.67%
17,887 $1.52 Million
Q2 2022

Aug 10, 2022
BUY
$71.48 - $86.85 $1,143 - $1,389
16 Added 0.08%
19,373 $1.61 Million
Q1 2022

May 10, 2022
SELL
$74.28 - $92.69 $519 - $648
-7 Reduced 0.04%
19,357 $1.49 Million
Q4 2021

Feb 04, 2022
BUY
$71.72 - $91.47 $44,107 - $56,254
615 Added 3.28%
19,364 $1.71 Million
Q3 2021

Nov 10, 2021
SELL
$74.77 - $85.47 $401,888 - $459,401
-5,375 Reduced 22.28%
18,749 $1.45 Million
Q2 2021

Aug 10, 2021
SELL
$75.51 - $84.79 $4,606 - $5,172
-61 Reduced 0.25%
24,124 $2.01 Million
Q1 2021

Aug 10, 2021
BUY
$74.73 - $90.69 $22,792 - $27,660
305 Added 1.28%
24,185 $1.83 Million
Q1 2021

May 11, 2021
SELL
$74.73 - $90.69 $200,650 - $243,502
-2,685 Reduced 10.11%
23,880 $1.8 Million
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $22,799 - $28,322
314 Added 1.2%
26,565 $2.33 Million
Q3 2020

Dec 10, 2020
BUY
$71.87 - $131.03 $1.68 Million - $3.06 Million
23,384 Added 815.63%
26,251 $2 Million
Q2 2020

Aug 10, 2020
BUY
$79.55 - $124.22 $2,704 - $4,223
34 Added 1.2%
2,867 $354,000
Q1 2020

May 18, 2020
BUY
$71.37 - $96.85 $999 - $1,355
14 Added 0.5%
2,833 $239,000
Q4 2019

Feb 13, 2020
BUY
$64.27 - $86.37 $181,177 - $243,477
2,819 New
2,819 $238,000
Q3 2019

Nov 12, 2019
SELL
$67.4 - $85.11 $183,665 - $231,924
-2,725 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $6,749 - $7,887
84 Added 3.18%
2,725 $233,000
Q1 2019

Apr 23, 2019
SELL
$84.2 - $98.62 $71,233 - $83,432
-846 Reduced 24.26%
2,641 $235,000
Q1 2019

Apr 12, 2019
BUY
$84.2 - $98.62 $293,605 - $343,887
3,487 New
3,487 $297,000

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email